Thryvv : ratio page

Alembic Pharma

Overview Articles Financials Ratios Shareholding Peers

Financial Ratios

View
Order
Financial Ratios
Mar2025
Mar2024
Mar2023
Mar2022
Mar2021
Valuation Parameters:
PE(x)
31.31
31.35
28.50
27.97
16.55
PCE(x)
21.22
21.73
15.79
18.04
14.61
Price/Book(x)
3.52
4.01
2.23
2.78
3.74
Yield(%)
1.18
1.12
1.61
1.35
1.45
EV/Net Sales(x)
2.90
3.15
1.82
2.85
3.59
EV/Core EBITDA(x)
18.43
20.39
14.49
16.37
12.35
EV/EBIT(x)
24.65
28.50
25.45
23.53
13.99
EV/CE(x)
3.03
3.74
2.06
2.09
2.78
MCap / Sales
2.74
3.10
1.72
2.75
3.52
Growth Ratio:
Net Sales Growth(%)
7.12
10.19
6.54
-1.62
17.10
Core EBITDA Growth(%)
9.27
35.24
-23.09
-41.02
27.66
EBIT Growth(%)
14.23
69.98
-37.06
-53.53
34.77
PAT Growth(%)
-5.49
80.07
-34.35
-53.27
39.23
EPS Growth(%)
-5.26
80.07
-34.35
-54.56
32.66
Financial Stability Ratios:
Total Debt/Equity(x)
0.23
0.09
0.15
0.12
0.10
Current Ratio(x)
1.67
2.07
1.78
1.63
1.89
Quick Ratio(x)
0.76
0.99
0.88
0.75
0.93
Interest Cover(x)
9.98
12.24
8.07
36.27
86.40
Total Debt/Mcap(x)
0.07
0.02
0.07
0.04
0.03
Operational & Financial Ratios:
Earnings Per Share (Rs)
29.68
31.33
17.40
26.50
58.33
CEPS(Rs)
43.78
45.20
31.41
41.09
66.05
DPS(Rs)
11.00
11.00
8.00
10.00
14.00
Book NAV/Share(Rs)
264.10
245.14
222.36
266.47
257.80
Tax Rate(%)
17.70
2.53
3.55
16.70
18.52
Margin Ratios:
Core EBITDA Margin(%)
15.03
14.97
12.53
16.48
27.44
EBIT Margin(%)
11.78
11.05
7.16
12.12
25.66
Pre Tax Margin(%)
10.60
10.14
6.27
11.79
25.37
PAT Margin (%)
8.72
9.89
6.05
9.82
20.67
Cash Profit Margin (%)
12.90
14.26
10.92
15.22
24.07
Performance Ratios:
ROA(%)
8.28
9.93
5.15
7.34
16.95
ROE(%)
11.63
13.40
7.12
10.11
26.91
ROCE(%)
13.51
13.42
7.44
11.25
26.28
Asset Turnover(x)
0.95
1.00
0.85
0.75
0.82
Sales/Fixed Asset(x)
1.67
1.70
1.79
1.97
2.31
Working Capital/Sales(x)
3.98
3.84
4.44
4.64
3.93
Efficiency Ratios:
Fixed Capital/Sales(x)
0.60
0.59
0.56
0.51
0.43
Receivable days
66.32
60.69
59.84
39.75
41.06
Inventory Days
107.54
91.38
99.60
106.49
90.48
Payable days
164.40
150.62
148.04
173.51
187.92